NUKLEARFAKTOR KB INDUZIERENDER FAKTOR

Patent europeic · EP1290023 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1290023
Numer da la dumonda
EP01920925
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
02-04-2001
Publitgà
12-03-2003
Concedì
27-10-2010
Stritgà
30-04-2015
Motiv
Taxa annuala betg pajada
Classas IPC
C07K 14/47 (2006.01)
A61K 38/00 (2006.01)
A61K 48/00 (2006.01)
Prioritad
US 193905 P 31.03.2000
GB 0018307 26.07.2000
Dumonda PCT
PCT/US2001/010719 02.04.2001
Publicaziun PCT
WO2001/074900 11.10.2001
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 18-11-2015

    Stritgà, taxa betg pajada

    Published in Swissreg on 18.11.2015

  2. 03-05-2011

    Adressa midada

    Owner
    Aventis Pharmaceuticals Inc., 300 Somerset Corporate Boulevard, Bridgewater, New Jersey 08807, USA → Aventis Pharmaceuticals Inc., 55 Corporate Drive, Bridgewater, NJ 08807, USA

    Published in Swissreg on 03.05.2011

  3. 03-05-2011

    Represchentant inscrit

    Representative
    Patentanwälte, Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich

    Published in Swissreg on 03.05.2011

  4. 27-10-2010

    Concedì

    Published in Swissreg on 27.10.2010

Partidas

Possessur

Aventis Pharmaceuticals Inc.

55 Corporate Drive, Bridgewater, NJ 08807, US

Represchentant

Patentanwälte Schaad, Balass, Menzl & Partner AG

Dufourstrasse 101, 8034 Zürich

Inventur

KAPLOW, June

Doylestown, PA 18901, US

HAWS, Thomas

Wilmington, DE 19803, US

ROSIER, Marie

F-92160 Antony, FR

DENEFLE, Patrice

F-94100 Saint Maur, FR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.